Our novel study on T2DM in northern Chinese Han patients supports the research by O'Donoghue et al. and provides complementary data to support the finding that future cardiovascular event risk in T2DM patients may be heightened by elevated circulating Lp(a) levels. The gene discussed is LPA; the disease is type 2 diabetes mellitus.